Skip to main content
. 2019 Sep 23;2019(9):CD013435. doi: 10.1002/14651858.CD013435

Osada 2012.

Methods RCT, parallel design
Participants Total number of randomized participants: 141
Inclusion criteria: scheduled for open‐heart surgery
Exclusion criteria: previous AF, undergoing emergency surgery
Type of surgery: open‐heart surgery (CABG, valve surgery, thoracic aorta surgery)
Baseline characteristics not reported. Study authors state "no significant differences between the two groups in baseline patient characteristics".
Country: Japan
Setting: single centre; hospital
Interventions Intervention group (landiolol)
  • Randomized, n = 73; losses = 0; analysed, n = 73

  • Details: landiolol hydrochloride 2‐3 µg/kg/min IV infusion, started soon after arrival in the ICU after surgery, continued for 48 h


Control group (standard care)
  • Randomized, n = 68; losses = 0; analysed, n = 68

  • Details: standard care, participants did not receive landiolol

Outcomes Outcomes measured/reported by study authors: AF
Outcomes relevant to the Review: AF
Notes Funding/declarations of interest: not reported
Study dates: May 2010‐January 2012
Note:
  • full study report not available, data taken from abstract only

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not specified
Allocation concealment (selection bias) Unclear risk Not specified
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Open‐label trial
Blinding of outcome assessors (detection bias) 
 All outcomes High risk Open‐label trial
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No losses
Selective reporting (reporting bias) Unclear risk Not detected (in abstract)
Other bias Unclear risk Limited detail in abstract and therefore, it is not feasible to assess risks of other bias